Last reviewed · How we verify
NCT06684808
Impact of Active Breaks in Elementary School Children
NA trial testing Fitness in Physical Performance in 159 participants. Completed in 31 May 2024.
30 April 2024
Quick facts
| Lead sponsor | University of Molise |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 159 |
| Start date | 1 December 2023 |
| Primary completion | 30 April 2024 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Fitness
- Creative
- Combined
- Control
Conditions studied
- Physical Performance — all drugs for Physical Performance →
- Cognitive Performance — all drugs for Cognitive Performance →
- Academic Acheivement — all drugs for Academic Acheivement →
Sponsor
University of Molise
Who can join
Adults 6 to 8, any sex, with Physical Performance or Cognitive Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study was to evaluate the effects of 12 weeks of Active Breaks on motor, academic and cognitive performance in elementary school children.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Active Breaks Enhance Complex Processing Speed, Math Performance, and Physical Activity in Primary School Children: A Randomized Controlled Trial.
Fiorilli G, Di Claudio G, Di Fonza D, Baralla F, et al · · 2025 · PMID 41133566 · DOI 10.3390/jfmk10040376
Verify or expand the search:
- PubMed search for NCT06684808
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Fitness
Trials testing the same drug.
- NCT06191822 — Aspire2B Personalization Pilot Study Program · NA · unknown
Other recruiting trials for Physical Performance
Currently open trials in the same condition.
- NCT07272876 — Kinesiophobia and Physical Function in Elderly With Musculoskeletal Pain · active not recruiting
- NCT07347522 — Body Composition and Lifestyle Factors in ROTC · recruiting
- NCT07378007 — Characteristics of Performance in Collegiate Cheerleaders and Dancers · recruiting
- NCT07107984 — Assessment of Physical Performance in Children · active not recruiting
- NCT06925880 — Effect of Micronized Creatine Monohydrate on Muscle Mass, Strength and Performance in Older Adults Submitted to Total Kn · NA · recruiting
Other University of Molise trials
Trials by the same sponsor.
- NCT06669598 — ENHANCING PHYSICAL and COGNITIVE EFFICIENCY in INDIVIDUALS AT RISK of DEMENTIA USING WHOLE-BODY ELECTROMYOSTIMULATION · NA · completed
- NCT06690853 — Effects of Coordinative Warm-Up Exercise Protocols on the Technical and Cognitive Performance of Soccer Players · NA · completed
- NCT07116044 — Assessment of Response and Safety of Bulevirtide Treatment in Patients With Chronic Delta Virus Infection · completed
- NCT04742855 — Probiotics for Blepharitis in Adults and Children · unknown
- NCT04742829 — Effects of a Therapy With INTRAVIT® Tablets in Patients With Diabetic Retinopathy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06684808 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Molise
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06684808.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing